Clonal hematopoiesis of indeterminate potential (CHIP), treatment outcomes and adverse events in gastrointestinal cancers: A pooled analysis of clinical trial and real-world data.

被引：1
|
作者：
Krishnan, Tharani
Vasconcelos, Joao Paulo Solar
Titmuss, Emma
Topham, James Thomas
Schaeffer, David F.
Karsan, Aly
Lim, Howard J.
Ho, Cheryl
Gill, Sharlene
Kennecke, Hagen Fritz
Jonker, Derek J.
Chen, Eric Xueyu
Renouf, Daniel John
O'Callaghan, Christopher J.
Loree, Jonathan M.
机构：
[1] BC Canc Vancouver, Vancouver, BC, Canada
[2] BCCA, Genome Sci Ctr, Vancouver, BC, Canada
[3] Univ British Columbia, BC Canc Vancouver, Vancouver, BC, Canada
[4] Providence Canc Inst, Portland, OR USA
[5] Ottawa Hosp, Canc Ctr, Ottawa, ON, Canada
[6] Univ Hlth Network, Toronto, ON, Canada
[7] Queens Univ, Canadian Canc Trials Grp, Kingston, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
3282-415-6705; 261-492-199-2823; 283-237-255; 130-231; 261-374; 261-566-148; 8; 4; 3; 3618; 3580; 2; 1; 38092-21872; 38092-33634; 38092-18438; 38092-18392;
D O I：
10.1200/JCO.2024.42.3_suppl.169
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：169 / 169
页数：1
相关论文
共 37 条
  • [1] Clonal hematopoiesis of indeterminate potential (CHIP): Outcomes and adverse events in patients with solid tumors
    Krishnan, Tharani
    Vasconcelos, Joao Paulo Solar
    Titmuss, Emma
    Topham, James T.
    Vanner, Robert
    Schaeffer, David F.
    Karsan, Aly
    Lim, Howard J.
    Ho, Cheryl
    Brown, Carl J.
    Gill, Sharlene
    Kennecke, Hagen Fritz
    Jonker, Derek J.
    Chen, Eric Xueyu
    Renouf, Daniel John
    O'Callaghan, Christopher J.
    Loree, Jonathan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] The Effect of Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Aspirin on Clinical Outcomes in the Healthy Elderly: A Sub-Study of the Aspirin in Reducing Events in the Elderly (ASPREE) Randomized Controlled Trial
    McQuilten, Zoe
    Wong, Nicholas C.
    Leichter, Anna
    Thao, Le T. P.
    Phung, James
    Murphy, Andrew J.
    Riaz, Moeen
    Sebra, Robert
    Bick, Alexander G.
    McNeil, John J.
    Wolfe, Rory
    Woods, Robyn L.
    Lacaze, Paul
    Wood, Erica M.
    Curtis, David J.
    BLOOD, 2022, 140 : 2238 - 2239
  • [3] Interim Analysis of Mmrf Curecloud Research Initiative Identifies High Prevalence and Patterns of Clonal Hematopoiesis of Indeterminate Potential (CHIP) Mutations in a Real World Myeloma Cohort
    Jayasinghe, Reyka G.
    Kim, Annette S.
    Dowdell, Teni
    Dowdell, Teni
    Cibulskis, Carrie
    Yesil, Jennifer
    Chatterjee, Debanjana
    Likens, Michael
    Mehr, Shaadi
    Saravanamuthu, Cartik
    Alberge, Jean-Baptiste
    Lapinskas, Emily
    Labkoff, Steven E.
    Ligon, Keith L.
    Cho, Hearn Jay
    Ghobrial, Irene M.
    Auclair, Daniel
    BLOOD, 2021, 138
  • [4] Efficacy of Eribulin mesylate in older patients with breast cancer: A pooled analysis of clinical trial and real-world data
    Pedersini, Rebecca
    di Mauro, Pierluigi
    Amoroso, Vito
    Parati, Maria Chiara
    Turla, Antonella
    Ghilardi, Mara
    Vassalli, Lucia
    Ardine, Mara
    Dalla Volta, Alberto
    Monteverdi, Sara
    Borgonovo, Karen
    Ghidini, Antonio
    Cabiddu, Mary
    Simoncini, Edda Lucia
    Petrelli, Fausto
    Berruti, Alfredo
    Barni, Sandro
    JOURNAL OF GERIATRIC ONCOLOGY, 2020, 11 (06) : 976 - 981
  • [5] Cardiovascular adverse events in oncology trials: understanding and appreciating the differences between clinical trial data and real-world reports
    Ewer, Michael S.
    Herson, Jay
    CARDIO-ONCOLOGY, 2022, 8 (01)
  • [6] Cardiovascular adverse events in oncology trials: understanding and appreciating the differences between clinical trial data and real-world reports
    Michael S. Ewer
    Jay Herson
    Cardio-Oncology, 8
  • [7] USE OF REAL-WORLD DATA AND MACHINE LEARNING TO REDUCE TREATMENT-LIMITING ADVERSE EVENTS IN AN ACUTE MYELOID LEUKEMIA CLINICAL TRIAL POPULATION
    Buderi, R.
    Ransom, J.
    Galaznik, A.
    Berger, M.
    VALUE IN HEALTH, 2020, 23 : S74 - S74
  • [8] Real-world treatment patterns, adverse events and clinical outcomes in patients with chronic lymphocytic leukaemia treated with ibrutinib in the UK
    Hillmen, Peter
    Xie, Jing
    Yong, Alan S. M.
    Waweru, Catherine
    Sorof, Thuy Anh
    Goyal, Ravi K.
    Davis, Keith L.
    EJHAEM, 2021, 2 (02): : 219 - 227
  • [9] Real-world Treatment Patterns and Clinical Outcomes Associated With Palbociclib Combination Therapy: A Multinational, Pooled Analysis From the Ibrance Real World Insights Study
    Mycock, Katie
    Hanson, Kent A.
    Taylor-Stokes, Gavin
    Milligan, Gary
    Atkinson, Christian
    Mitra, Debanjali
    Preciado, Salena
    Law, Ernest H.
    CLINICAL THERAPEUTICS, 2022, 44 (12) : 1588 - 1601
  • [10] Real-world treatment patterns, adverse events and clinical outcomes in patients with chronic lymphocytic leukaemia treated with ibrutinib in the United Kingdom
    Xie, J.
    Yong, A. S. M.
    Waweru, C.
    Sorof, T. -A.
    Goyal, R. K.
    Davis, K. L.
    Hillmen, P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 221 - 221
1234